Tennessee HB1198 amends state codes to integrate biosimilar medicines into existing drug regulations and coverage requirements.
Tennessee HB1198 amends several sections of Tennessee Code Annotated to include biosimilar medicines in existing regulations and coverage requirements. It adds "or biosimilars" to relevant subsections and removes barriers for patients needing coverage for biosimilars. The act aims to eliminate barriers to accessing biosimilar medicines, which are FDA-approved for quality, safety, and efficacy. The changes take effect immediately upon becoming law.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.